Zhuhai Jianfu Pharmaceutical

Zhuhai Jianfu Pharmaceutical is a prominent subsidiary of Jafron Biomedical, a leading global provider of blood purification products and services. Based in Zhuhai, China, the company focuses on the commercialization and distribution of advanced hemoperfusion cartridges and immunoadsorption columns. Its flagship HA series of cartridges is widely utilized in the treatment of end-stage renal disease, acute poisoning, and critical care conditions such as sepsis. By leveraging proprietary adsorbent resin technology, the company provides life-saving extracorporeal therapies that remove specific toxins and inflammatory mediators from the bloodstream. Zhuhai Jianfu Pharmaceutical plays a critical role in maintaining Jafron's market leadership in the Chinese blood purification sector while expanding its international footprint.